Joy Yan - 20 Jun 2022 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
Director
Signature
/s/ Jonathan Foster by Power of Attorney
Issuer symbol
MBRX
Transactions as of
20 Jun 2022
Transactions value $
$0
Form type
4
Filing time
22 Jun 2022, 19:02:36 UTC
Previous filing
31 May 2022
Next filing
26 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock option (right to buy) Award +23,333 +3.5% 30,000 20 Jun 2022 Common Stock 23,333 $1.49 Direct F1, F3
transaction MBRX Stock option (right to buy) Award +15,000 +50% 45,000 20 Jun 2022 Common Stock 15,000 $1.49 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
F2 The options set forth in this table vest on the earlier of one year from the date of the Company's 2022 annual meeting of stockholders or on the date of the next annual meeting of stockholders, subject the grantee's continued service on the Company's Board of Directors on each vesting date.
F3 The options were issued in connection with the reporting person's Board of Director service to the Company.